Drug Shortage Report for FUROSEMIDE INJECTION SDZ

Last updated on 2025-04-07 History
Report ID 247601
Drug Identification Number 02382539
Brand name FUROSEMIDE INJECTION SDZ
Common or Proper name FUROSEMIDE INJECTION SDZ
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FUROSEMIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2ML
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-01-13
Estimated end date 2025-08-01
Actual end date
Shortage status Actual shortage
Updated date 2025-04-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-04-07 French Compare
v10 2025-04-07 English Compare
v9 2025-03-31 French Compare
v8 2025-03-31 English Compare
v7 2025-03-17 French Compare
v6 2025-03-17 English Compare
v5 2025-02-17 French Compare
v4 2025-02-17 English Compare
v3 2025-01-13 French Compare
v2 2025-01-13 English Compare
v1 2025-01-13 English Compare

Showing 1 to 11 of 11